" />

Latest Cover

Online Office

Contact Us

Issue:ISSN 1000-7083
          CN 51-1193/Q
Director:Sichuan Association for Science and Technology
Sponsored by:Sichuan Society of Zoologists; Chengdu Giant Panda Breeding Research Foundation; Sichuan Association of Wildlife Conservation; Sichuan University
Address:College of Life Sciences, Sichuan University, No.29, Wangjiang Road, Chengdu, Sichuan Province, 610064, China
Email:[email protected] & [email protected]
Your Position :Home->Past Journals Catalog->2020 Vol.39 No.1

Inhibitory Effect of Single Gene and Double Gene Combined Therapy Drugs on the Growth of B16-F10 Melanoma in Mice
Author of the article:WEI Shiyuan1, TANG Fang1, PENG Xu2, HE Xueling2, YIN Hailin2*
Author's Workplace:1. College of Life Sciences, Sichuan University, Chengdu 610065, China;
2. Experimental Animal Center, Sichuan University, Chengdu 610041, China
Key Words:B16-F10 melanoma; granulocyte-macrophage colony-stimulating factor; vascular endothelial growth factor; gene therapy
Abstract:Objective To study the effect of cationic liposome-mediated mGM-csf and mFlt-kdr3 gene therapy and combined gene therapy on lung metastasis and tumor growth inhibition of mouse B16-F10 melanoma.Methods The lung metastasis model and subcutaneous solid tumor model were established by injecting 105and 106 melanoma cells into BALB/c mice by caudal vein injection and subcutaneous injection, respectively. The mice of the 2 groups were divided into 5 subgroups: mFlt-kdr3 group, mGM-csf group, combined treatment group (1 mFlt-kdr3, 2 mGM-csf), empty vector plasmid group, and normal saline control group. After the model was established for 3 weeks, the mice with pulmonary metastasis began to be treated by intravenous injection of drugs (80 μL per time, 1 day interval, a total of 3 times). After 3 days, the lung tissue was dissected and the tumor foci were counted, and HE staining was performed. The solid tumor mouse models were treated with tumor puncture administration for one week (25 μL per dose, 1 day interval, a total of 9 times). In the meantime, the length of mouse tumor were measured with vernier caliper before each administration.Results The average number of tumor in the treatment group was much lower than that in the control group (P<0.05). The number of tumor in the combined treatment group was the least, and the lung structure was intact. Obvious alveolar structure can be observed by HE staining. In the solid tumor model test, the average tumor volume in the treatment group was much lower than that in the control group (P<0.05), and the average tumor volume in the combined treatment group was the most obvious during the experiment. The combined treatment group had the highest therapeutic effect, followed by mFlt-kdr3 group and mGM-csf group.Conclusion GM-csf and Flt-kdr3 gene therapeutic drugs have synergistic effect on melanoma, which can inhibit the formation of lung tumor focus and the growth of solid tumor.
2020,39(1): 34-40 收稿日期:2019-05-16
作者簡介:韋世元(1994-),碩士研究生,主要從事實驗動物相關研究,E-mail:[email protected]
*通信作者:尹海林,E-mail:[email protected]
馬銳, 夏海濱. 2017. 針對抗腫瘤血管生成的分子靶向治療進展[J]. 細胞與分子免疫學雜志, 33(3):423-427.
田萍, 鄭玲. 2017. 惡性黑色素瘤的基因靶向治療及生物免疫治療的研究現狀[J]. 實用藥物與臨床, 20(5):593-597.
張佳奇, 趙路軍, 劉寧波, 等. 2018. 粒細胞-巨噬細胞集落刺激因子聯合放療研究進展[J]. 中國腫瘤臨床, 45(9):468-471.
Bartolom RA, Torres S, de Val SI, et al. 2017. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers[J]. Oncotarget, 8(1):215-227.
Brenner BM, Hostetter TH, Humes HD. 1978. Glomerular permselectivity:barrier function based on discrimination of molecular size and charge[J]. The American Journal of Physiology, 234(6):455-460.
Davidoff AM, Nathwani AC, Spurbeck WW, et al. 2002. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice[J]. Cancer Research, 62(11):3077-3083.
Hodi FS, Butler M, Oble DA, et al. 2008. Immunologic and clinical effects of antibody blockade of cytotoxic t lymphocyte-associated antigen 4 in previously vaccinated cancer patients[J]. Proceedings of the National Academy of Sciences of the United States of America, 105(8):3005-3010.
RaziSoofiyani S, Kazemi T, Lotfipour F, et al. 2017. The effects of gene therapy with granulocyte-macrophage colony-stimulating factor in the regression of tumor masses in fibrosarcoma mouse model[J]. Journal of Cancer Research & Therapeutics, 13(2):362-366.
Sallinen H, Anttila M, Narvainen J, et al. 2009. Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice[J]. Molecular Therapy, 17(2):278-284.
Tada F, Abe M, Hirooka M, et al. 2012. Phase Ⅰ/Ⅱ study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma[J]. International Journal of Oncology, 41(5):1601-1609.
Templeton NS, Lasic DD, Frederik PM, et al. 1997. Improved DNA:liposome complexes for increased systemic delivery and gene expression[J]. Nature Biotechnology, 15(7):647-652.
Yu TW, Chueh HY, Tsai CC, et al.2016. Novel GM-CSF-based vaccines:one small step in GM-CSF gene optimization, one giant leap for human vaccines[J]. Human Vaccines & Immunotherapeutics, 12(1):3020-3028.
Zhang X, Wang S, Nan Y, et al. 2018. Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma[J]. Applied Microbiology and Biotechnology, 102(15):6503-6513.
CopyRight©2020 Editorial Office of Sichuan Journal of Zoology